Solid Biosciences (SLDB)
US Market

Solid Biosciences (SLDB) Financial Statements


Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently ―. The company's EPS TTM is $-10.193; its P/E ratio is -0.37; Solid Biosciences is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $-2.27. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 6.17M$ 1.93M$ 3.15M$ 3.54M
Gross Profit-----
EBIT$ -21.13M$ -23.86M$ -25.37M$ -18.65M$ -18.03M
EBITDA$ -20.69M$ -23.14M$ -24.66M$ -17.89M$ -17.28M
Net Income Common Stockholders$ -20.41M$ -25.09M$ -25.33M$ -18.61M$ -17.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 142.16M$ 162.88M$ 180.05M$ 207.78M$ 229.76M
Total Assets$ 184.47M$ 208.50M$ 207.56M$ 232.38M$ 248.99M
Total Debt$ 25.69M$ 24.99M$ 1.52M$ 2.06M$ 2.27M
Net Debt$ -116.47M$ -137.90M$ -178.53M$ -205.72M$ -227.49M
Total Liabilities$ 41.20M$ 46.26M$ 22.05M$ 24.17M$ 25.62M
Stockholders Equity$ 143.28M$ 162.24M$ 185.51M$ 208.21M$ 223.36M
Cash Flow-
Free Cash Flow$ -21.27M$ -17.01M$ -27.37M$ -21.53M$ -18.66M
Operating Cash Flow$ -20.43M$ -15.88M$ -27.19M$ -20.87M$ -18.42M
Investing Cash Flow$ 14.91M$ -59.59M$ 37.74M$ 30.18M$ -72.51M
Financing Cash Flow$ -1.00K$ 73.00K$ 22.00K$ 66.00K$ 3.00K
Currency in USD

Solid Biosciences Earnings and Revenue History

Solid Biosciences Debt to Assets

Solid Biosciences Cash Flow

Solid Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis